Skip to main content

Context Therapeutics Inc.

CNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001842952

No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Context Therapeutics Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
34
+10 vs. Q1 2024
Shares held
57.0M
+53.1M (+1,349.4%) vs. Q1 2024
Total value
$114.3M
+$108.9M (+2,005.2%) vs. Q1 2024
New holders
19
8 more added
Sold out
9
3 more reduced

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 34 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 19 institutionsQ1 2022: 16 institutionsQ2 2022: 20 institutionsQ3 2022: 24 institutionsQ4 2022: 24 institutionsQ1 2023: 22 institutionsQ2 2023: 22 institutionsQ3 2023: 23 institutionsQ4 2023: 24 institutionsQ1 2024: 25 institutionsQ2 2024: 34 institutionsQ3 2024: 42 institutionsQ4 2024: 52 institutionsQ1 2025: 42 institutionsQ2 2025: 39 institutionsQ3 2025: 37 institutionsQ4 2025: 43 institutionsQ1 2026: 60 institutionsQ2 2026: 79 institutions
Value heldQ2 2024: $114.3M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $9.44MQ1 2022: $6.30MQ2 2022: $6.32MQ3 2022: $4.59MQ4 2022: $2.55MQ1 2023: $722.6KQ2 2023: $3.58MQ3 2023: $3.89MQ4 2023: $4.02MQ1 2024: $5.43MQ2 2024: $114.3MQ3 2024: $111.2MQ4 2024: $76.4MQ1 2025: $43.7MQ2 2025: $45.0MQ3 2025: $66.8MQ4 2025: $96.0MQ1 2026: $194.6MQ2 2026: $34.8M
Institutions holding CNTX and their total value by quarter
QuarterHoldersValue
Q2 202679$34.8M
Q1 202660$194.6M
Q4 202543$96.0M
Q3 202537$66.8M
Q2 202539$45.0M
Q1 202542$43.7M
Q4 202452$76.4M
Q3 202442$111.2M
Q2 202434$114.3M
Q1 202425$5.43M
Q4 202324$4.02M
Q3 202323$3.89M
Q2 202322$3.58M
Q1 202322$722.6K
Q4 202224$2.55M
Q3 202224$4.59M
Q2 202220$6.32M
Q1 202216$6.30M
Q4 202119$9.44M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q1 2024.

Institutions holding CNTX in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Great Point Partners LLC7,419,355$14.9M2.85%+7,419,355New
Avidity Partners Management LP7,419,355$14.9M0.63%+7,419,355New
Deep Track Capital, LP7,419,355$14.9M0.44%+7,419,355New
Nextech Invest AG7,419,355$14.9M2.50%+7,419,355New
Blue Owl Capital Holdings LP5,161,290$10.3M2.88%+5,161,290New
Vanguard Group Inc4,502,198$9.03M0.00%+3,903,895+652.5%Added
Driehaus Capital Management LLC2,258,065$4.53M0.04%+2,258,065New
Nantahala Capital Management, LLC1,935,484$3.88M0.39%+1,935,484New
Alyeska Investment Group, L.P.1,935,484$3.85M0.02%+1,935,484New
Ally Bridge Group (NY) LLC1,886,232$3.78M2.25%+1,160,281+159.8%Added
Blackstone Group Inc.1,838,709$3.69M0.02%+1,838,709New
Affinity Asset Advisors, LLC1,619,140$3.25M0.51%+1,290,323+392.4%Added
Sio Capital Management, LLC1,328,352$2.66M1.00%+1,328,352New
Velan Capital Investment Management LP1,290,323$2.59M1.48%+1,290,323New
BlackRock Inc.851,696$1.71M0.00%+851,696New
ADAR1 Capital Management, LLC645,161$1.29M0.26%+439,227+213.3%Added
Geode Capital Management, LLC618,174$1.24M0.00%+517,102+511.6%Added
Altium Capital Management LP360,001$721.8K0.30%+360,001New
UBS Oconnor LLC293,758$589.0K0.02%−2,917−1.0%Reduced
Northern Trust Corp174,497$349.9K0.00%+137,278+368.8%Added
HighTower Advisors, LLC125,852$252.0K0.00%00.0%Unchanged
Walleye Capital LLC108,376$217.3K0.00%+108,376New
Mill Creek Capital Advisors, LLC104,631$209.8K0.01%00.0%Unchanged
State Street Corp92,107$184.7K0.00%+59,200+179.9%Added
Renaissance Technologies LLC65,200$130.7K0.00%+25,300+63.4%Added
Bridgeway Capital Management, LLC41,469$83.1K0.00%−64,340−60.8%Reduced
Clear Harbor Asset Management, LLC36,000$72.2K0.01%00.0%Unchanged
ExodusPoint Capital Management, LP24,750$50.0K0.00%+24,750New
Caxton Corp18,403$36.9K0.19%+18,403New
Verition Fund Management LLC16,294$32.7K0.00%+16,294New
Two Sigma Investments, LP13,844$27.8K0.00%+13,844New
Bank of America Corp10,776$21.6K0.00%+10,776New
Advisor Group Holdings, Inc.500$1.00K0.00%−1,000−66.7%Reduced
Federation des caisses Desjardins du Quebec400$8020.00%00.0%Unchanged
Opaleye Management Inc.0$00.00%−1,108,357−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−22,389−100.0%Sold out
Sheets Smith Wealth Management0$00.00%−20,000−100.0%Sold out
Citadel Advisors LLC0$00.00%−15,041−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−11,453−100.0%Sold out
XTX Topco Ltd0$00.00%−10,261−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−6,357−100.0%Sold out
Wells Fargo & Company0$00.00%−116−100.0%Sold out
JPMorgan Chase & Co0$00.00%−33−100.0%Sold out
Retirement Group, LLC––––Not filed